Apyx Medical Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +22.4% | -30.1% | +18.6% | -5.4% | +23.8% | -33.7% | +20.6% | +13.2% | +48.8% | -34.8% | +11.2% | – | |
| – | +165.1% | -59.5% | +117.4% | -51.5% | +16.0% | -28.4% | +13.9% | +6.8% | +362.4% | -63.1% | -35.9% | – | |
| – | -49.1% | +46.5% | -52.7% | +147.4% | +28.9% | -36.8% | +25.0% | +17.1% | -124.2% | – | +89.9% | – | |
| – | -11.4% | +11.9% | +1.9% | -19.8% | -2.2% | -28.0% | +2.5% | -2.8% | +17.9% | -19.0% | +3.7% | – | |
| – | +20.1% | -17.0% | +4.0% | -18.7% | +15.3% | -27.4% | +11.6% | -83.2% | +645.7% | -26.9% | +22.5% | – | |
| – | -22.0% | +27.7% | -33.5% | +26.7% | +13.4% | -27.4% | +10.8% | -5.5% | -122.2% | – | +91.2% | – | |
| – | – | – | – | – | – | – | – | – | – | -8,381.8% | – | – | |
| – | +90.8% | +25.1% | +2.2% | +0.3% | +15.5% | -16.8% | +1.2% | +1.4% | -0.4% | -2.7% | +1.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -39.1% | -5.7% | +20.0% | +48.3% | -44.9% | +0.0% | +59.2% | +20.5% | +52.1% | -13.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -189.0% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.